A Randomized Phase 2 KINETIC Trial Evaluating SAGE-324/BIIB124 in Individuals with Essential Tremor.
Rodger J ElbleWilliam G OndoKelly E LyonsMin QinSvetlana GarafolaBonnie HershTinaMarie LieuDimitrios ArkiloRosalind ChuangKemi BankoleRajesh PahwaPublished in: Movement disorders : official journal of the Movement Disorder Society (2024)
These results support further development of SAGE-324/BIIB124 for potential ET treatment. © 2024 Sage Therapeutics, Inc and The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.